<DOC>
	<DOCNO>NCT00799591</DOCNO>
	<brief_summary>This study describe clinical outcome safety data collect prospectively subject hospitalize intensive care unit ( ICU ) present infection treatment tigecycline , alone combination , plan . Data collect subject provide informed consent .</brief_summary>
	<brief_title>French Study In ICU Patients Treated With Tigecycline</brief_title>
	<detailed_description>Healthcare visit . Extension Rationale : In order perform necessary corrective action require secure database consistency , request extension post Basic Results due 26-May-2011 protocol 3074A1-4448 ( B1811030 ) , NCT00799591 . Our propose submission date 14-Sept-2011 . Pfizer acquire Wyeth October 16 , 2009 . With regard study , reconciliation data identify discrepancy data list Project database ( manage CRO ) Safety Database ( manage Pfizer ) . We take corrective action involve : sending query investigator , collect corrective sign form , implement change within database . We request extension complete work data treat final CSR complete .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<criteria>Adult men woman ( 18 year ) . Subjects hospitalize medical surgical intensive care unit ( ICU ) ( day enrolment study ) . Subjects treat tigecycline ( first , second third line ) , say treatment freely choose participate physician , prior enrollment study . Subjects participate another biomedical research study . Patient ( legal representative ) date sign informed consent document .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Registre MONTRAVERS</keyword>
</DOC>